Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Gross Margin %: 90.15% (As of Mar. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688566 Jiangsu Jibeier Pharmaceutical Co Ltd SHSE:688566
85 GF Score
Price ¥24.06
GF Value ¥35.31
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Jiangsu Jibeier Pharmaceutical Co Gross Margin %?

Jiangsu Jibeier Pharmaceutical Co SHSE:688566 -1.39% 85 Gross Margin % is 90.15% as of Mar. 2026, which is 2% above its 10-year median of 88.30. GuruFocus rates SHSE:688566 with a GF Score™ of 85/100 and a GF Value™ of ¥35.31 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 941 Drug Manufacturers companies, Jiangsu Jibeier Pharmaceutical Co ranks better than 97.24% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Jiangsu Jibeier Pharmaceutical Co's Gross Profit for the three months ended in Mar. 2026 was ¥204.1 Mil. Jiangsu Jibeier Pharmaceutical Co's Revenue for the three months ended in Mar. 2026 was ¥226.4 Mil. Therefore, Jiangsu Jibeier Pharmaceutical Co's Gross Margin % for the quarter that ended in Mar. 2026 was 90.15%.


The historical rank and industry rank for Jiangsu Jibeier Pharmaceutical Co's Gross Margin % or its related term are showing as below:

SHSE:688566' s Gross Margin % Range Over the Past 10 Years
Min: 84.56   Med: 88.3   Max: 89.6
Current: 89.6


During the past 10 years, the highest Gross Margin % of Jiangsu Jibeier Pharmaceutical Co was 89.60%. The lowest was 84.56%. And the median was 88.30%.

SHSE:688566's Gross Margin % is ranked better than
97.24% of 941 companies
in the Drug Manufacturers industry
Industry Median: 48.54 vs SHSE:688566: 89.60

Jiangsu Jibeier Pharmaceutical Co had a gross margin of 90.15% for the quarter that ended in Mar. 2026 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Jiangsu Jibeier Pharmaceutical Co was 0.30% per year.


Jiangsu Jibeier Pharmaceutical Co  (SHSE:688566) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Jiangsu Jibeier Pharmaceutical Co had a gross margin of 90.15% for the quarter that ended in Mar. 2026 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Jiangsu Jibeier Pharmaceutical Co Gross Margin % Related Terms


Jiangsu Jibeier Pharmaceutical Co Gross Margin % Historical Data

* Premium members only.

The historical data trend for Jiangsu Jibeier Pharmaceutical Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Jibeier Pharmaceutical Co Gross Margin % Chart

Jiangsu Jibeier Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.81 88.37 88.95 89.38 89.46

Jiangsu Jibeier Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.57 89.96 89.50 88.85 90.15

SHSE:688566 vs ZTS, UTHR: Gross Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Jibeier Pharmaceutical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Jibeier Pharmaceutical Co Gross Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Jibeier Pharmaceutical Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Jiangsu Jibeier Pharmaceutical Co's Gross Margin % falls into.


SHSE:688566
85GF Score
Jiangsu Jibeier Pharmaceutical Co Ltd SHSE:688566
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Jibeier Pharmaceutical Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Jiangsu Jibeier Pharmaceutical Co's Gross Margin for the fiscal year that ended in Dec. 2025 is calculated as

Gross Margin % (A: Dec. 2025 )=Gross Profit (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=864.2 / 966.065
=(Revenue - Cost of Goods Sold) / Revenue
=(966.065 - 101.82) / 966.065
=89.46 %

Jiangsu Jibeier Pharmaceutical Co's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=204.1 / 226.417
=(Revenue - Cost of Goods Sold) / Revenue
=(226.417 - 22.303) / 226.417
=90.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 90.15% mean?
Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) has a Gross Margin % of 90.15% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Jiangsu Jibeier Pharmaceutical Co and its competitors. This is near median its historical median of 88.30. Over the past decade, Jiangsu Jibeier Pharmaceutical Co's Gross Margin % has ranged from 84.56 to 89.60. According to the industry distribution chart, Jiangsu Jibeier Pharmaceutical Co ranks #26 out of 941 companies in the Drug Manufacturers industry, placing it in the top 2.8%.
Is Jiangsu Jibeier Pharmaceutical Co's Gross Margin % too high?
Jiangsu Jibeier Pharmaceutical Co's current Gross Margin % of 90.15% is near median its 10-year median of 88.30. Over the past 10 years, this metric has ranged from a low of 84.56 to a high of 89.60. The Drug Manufacturers industry median Gross Margin % is 48.54. Jiangsu Jibeier Pharmaceutical Co's value of 90.15% is 85.7% above this industry median. Based on the distribution chart, Jiangsu Jibeier Pharmaceutical Co ranks #26 out of 941 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jiangsu Jibeier Pharmaceutical Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Jibeier Pharmaceutical Co's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangsu Jibeier Pharmaceutical Co ranks #26 out of 941 companies for Gross Margin %. This places Jiangsu Jibeier Pharmaceutical Co in the top 3% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. Jiangsu Jibeier Pharmaceutical Co's value of 90.15% is 85.7% above this benchmark. Historically, Jiangsu Jibeier Pharmaceutical Co's own Gross Margin % has ranged from 84.56 to 89.60 over the past decade. While the company's 10-year median is 88.30 vs. the industry median of 48.54, Jiangsu Jibeier Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 941 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Jibeier Pharmaceutical Co's current Gross Margin % of 90.15% is 85.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Jiangsu Jibeier Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Jibeier Pharmaceutical Co's current Gross Margin % is 90.15%, which is near median its own 10-year median of 88.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Jibeier Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥35.31, compared to a current price of ¥24.06 — trading 31.9% below its estimated fair value. The current Gross Margin % is 90.15%, which is near median its 10-year median of 88.30 and 85.7% above the Drug Manufacturers industry median of 48.54. Jiangsu Jibeier Pharmaceutical Co's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Jiangsu Jibeier Pharmaceutical Co (SHSE:688566), the current Gross Margin % is 90.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Jibeier Pharmaceutical Co (SHSE:688566) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Jibeier Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥24.06 is trading 31.9% below its estimated GF Value™ of ¥35.31. GuruFocus considers Jiangsu Jibeier Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for SHSE:688566:

  • Gross Margin %: 90.15% (near median its 10-year median of 88.30)
  • GF Value™: ¥35.31 vs. price of ¥24.06 (31.9% below fair value)
  • GF Score™: 85/100 with 1 warning sign
  • Industry Position: 85.7% above the Drug Manufacturers median (#26 of 941)

No single metric tells the full story. See the SHSE:688566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jiangsu Jibeier Pharmaceutical Co Business Description

Address High-tech Industrial Development Zone, Jiangsu Province, Zhenjiang, CHN, 212000
Jiangsu Jibeier Pharmaceutical Co Ltd specializes in the research, development, production and sales of chemical preparations, proprietary Chinese medicine preparations, and bulk medicines. The company's products include tablets, hard capsules, eye drops, and gels, agents, creams and other dosage. Its products are used in various application fields such as Cardiovascular drugs, Blood system drugs, Immune system drugs, Ophthalmic drugs, Antipyretic and analgesic drugs, Respiratory medicine, and other.
85GF Score

Get the complete analysis for SHSE:688566

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥24.06
Price
¥35.31
GF Value